B. Riley Securities analyst Lucas Pipes maintains Alpha Metallurgical (NYSE:AMR) with a Buy and raises the price target from $181 to $182.
Merck & Co Accused of Underplaying Mental Health Risks from Asthma and Allergy Drug Singulair
Initially, when released in 1998, Merck & Co Inc's (NYSE: MRK) asthma and allergy drug, Singulair, claimed side effects were mild and similar to a placebo, and the label stated that its distribution in the brain was "minimal," with no mention of psychiatric side effects.
